Please assess the completion status of the following clinical trial:

Trial Title: Fluorescence Imaging in Head and Neck Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Adults aged 18 years or older will be considered eligible.~* Patients with head and neck malignancies, such as melanoma, non-melanoma cutaneous malignancies, or oral cavity squamous cell carcinoma. Patients with central neck pathology including thyroid neoplasms, parathyroid neoplasms, and laryngeal neoplasms undergoing surgical resection.~  * Candidates for sentinel lymph node biopsy or central neck surgery~ * Newly diagnosed with clinically node negative head and neck cancer being staged with sentinel lymph node biopsy.~* Not pregnant or breast feeding.~* Able to understand and willing to sign an IRB-approved written informed consent document.~* Able to understand written or spoken English.~Exclusion Criteria:~* History of allergy to iodide drugs or shellfish (iodine allergy)~* Pregnant or breast feeding~* Do not fit age criteria~* Prisoners~* Unable to provide written consent~* Contraindications for surgery~  \*Presence of uncontrolled intercurrent illness including, but not limited to, ongoing or active infection of the head and neck, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements~* Receiving any other investigational agents

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Arm 1: Goggle Imaging (Type: EXPERIMENTAL): -Patient will then be taken to the operating room for this surgical procedure. Prior to starting the operation, the patient will undergo injection of ICG around the tumor per standard techniques while in the operating room. Those undergoing intraoperative visualization of parathyroid glands will not have any administration of ICG as these glands autofluoresce. Patients will then undergo the standard SLN biopsy procedure (those undergoing parathyroid visualization will not undergo this). The surgeon will put on the goggle system to attempt to identify the SLN using fluorescence guidance or parathryroid visualization. After this is performed, the goggle system will be removed and the procedure will be completed per normal.

Based on this trial design, predict the completion outcome and termination type (if applicable).